Ribbon Bio
PrivateLast Round
Series A
Jan 31, 2022
Total Funding Raised
$21.83M
Company Overview
Ribbon Bio operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Series A round in January 2022.
Ribbon Bio is a synthetic biology company that provides an automated, enzyme-based technology platform for the synthesis of long and complex DNA molecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ribbon Bio Comparables
Compare Ribbon Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ansa Biotechnologies | 87% | |
| NunaBio Limited | 84% | |
| Synplogen Co., Ltd. | 84% |
For institutional investors. Book with your work email.
Ribbon Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 31, 2022 | ||||
| Pre Seed | Mar 8, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ribbon Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| tecnet equity | Pre Seed, Series A |
| Vienna Business Agency | Grant |
| Austria Wirtschaftsservice | Grant, Pre Seed |
| xista science ventures | Pre Seed, Series A |
| European Commission | Grant |
| FFG Austrian Research Promotion Agency | Grant |
| Helicase Venture | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 142% MoM.
- Nov 20, 2025
Presented at AMM Ascent and launched an early access program for its Cell-Free product.
For institutional investors. Book with your work email.
Ribbon Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ribbon Bio's valuation, stock price, and market status.
Is Ribbon Bio a public or private company?
Ribbon Bio is a private company.
What is the current stock price of Ribbon Bio?
Ribbon Bio is a private company, so its shares have no public market price. Caplight tracks Ribbon Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ribbon Bio worth (valuation)?
Valuation information for Ribbon Bio is not publicly available.
Can I buy Ribbon Bio stock?
Ribbon Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ribbon Bio's last funding round?
Ribbon Bio's most recent funding round was Series A on January 31, 2022.
Who are the main investors in Ribbon Bio?
Key investors in Ribbon Bio include Hadean Ventures.
Will Ribbon Bio IPO soon?
No public IPO plans have been announced for Ribbon Bio.
How can I track Ribbon Bio secondary market activity?
Caplight tracks bids, offers, and trades in Ribbon Bio's shares on secondary markets.